A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain

Clinical trial NCT05445167 · COMPLETED

Trial details

NCT number: NCT05445167
Sponsor: Kissei Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Uterine Fibroids (MeSH Heading: Leiomyoma)

Start date: 2022-10-11
Primary completion: 2024-02-16
Enrollment: 89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.